| Literature DB >> 34830084 |
Mariya Borovaya1, Inna Horiunova1, Svitlana Plokhovska1, Nadia Pushkarova1, Yaroslav Blume1, Alla Yemets1.
Abstract
Ag-based quantum dots (QDs) are semiconductor nanomaterials with exclusive electrooptical properties ideally adaptable for various biotechnological, chemical, and medical applications. Silver-based semiconductor nanocrystals have developed rapidly over the past decades. They have become a promising luminescent functional material for in vivo and in vitro fluorescent studies due to their ability to emit at the near-infrared (NIR) wavelength. In this review, we discuss the basic features of Ag-based QDs, the current status of classic (chemical) and novel methods ("green" synthesis) used to produce these QDs. Additionally, the advantages of using such organisms as bacteria, actinomycetes, fungi, algae, and plants for silver-based QDs biosynthesis have been discussed. The application of silver-based QDs as fluorophores for bioimaging application due to their fluorescence intensity, high quantum yield, fluorescent stability, and resistance to photobleaching has also been reviewed.Entities:
Keywords: fluorescence imaging; near-infrared; photoluminescence; silver-based QDs; “green” synthesis
Mesh:
Substances:
Year: 2021 PMID: 34830084 PMCID: PMC8620749 DOI: 10.3390/ijms222212202
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Emission wavelength range of Ag-based QDs.
Classification of Ag-based QDs.
| Type of | Band Gap (eV) | Crystal Structure | Phase | References |
|---|---|---|---|---|
| Chalcogenides | ||||
| Ag2S | 0.9–1.1 | Monoclinic acanthite | Below 179 | [ |
| Body-centered cubic argentite form | Above 180 | |||
| Face-centered cubic | Above 586 | |||
| Ag2Se | 0.02–0.22 | Orthorhombic structure | ~133 | [ |
| Body-centered cubic form | Until 897 | |||
| Ag2Te | 0.67 | Monoclinic phase (β-form) | Transition at ~150 | [ |
| Cubic phase (α-form superionic conductor) | ||||
| Ternary dichalcogenides | 1.8 | Cubic structure | >100 | [ |
| AgInS2 | ||||
| AgInSe2 | 1.24–1.53 | Chalcopyrite phase | 300 | [ |
| Metastable orthorhombic phase | 250 | |||
| Quaternary dichalcogenides | 1.7 | Hexagonal structure | <100 | [ |
| ZnAgInS | ||||
| ZnAgInSe | 1.2 | Orthorhombic | 200–250 | [ |
Figure 2Schematic diagram of main types of Ag-based QDs.
Methods of chemical synthesis of Ag-based quantum dots and their characterization.
| Type of Quantum Dot | Chemical Synthesis Method | Average | Morphology | Photoluminescence (nm) | Crystal Lattice Structure | References |
|---|---|---|---|---|---|---|
| Ag2S | Single source precursor | 5–10 | Spherical | 543 | Orthorhombic or | [ |
| Sol-gel synthesis | 30–60 | Thin films | - | - | [ | |
| Hydrothermal method | 70–90 in length | Rice-shaped | - | Monoclinic | [ | |
| Gamma-ray irradiation | 200–500 | Rod-like | - | Monoclinic | [ | |
| Hydrothermal method | 1.45–5.20 | Spherical | 748–840 | Monoclinic | [ | |
| Pyrolysis method | 10.2 ± 0.4 | - | 1058 | - | [ | |
| Hot-injection method | 1.5–4.6 | Spherical | 690–1227 | |||
| Hydrothermal method | 2.6–3.7 | Spherical | 687–1096 | |||
| Microwave-assisted synthesis | 5.7 ± 0.93 | - | 1062 | |||
| Ag2Se | Co-precipitation method | 5–30 | Wire-type | 700–1330 | Orthorhombic | [ |
| Solvothermal method | 3.4 | Spherical | ẞ-Ag2Se | |||
| Hydrothermal method | 60–80 in length | Rice-shaped | - | |||
| Hydrothermal method | 3.1–3.9 | Spherical | 1080–1330 | Orthorhombic | [ | |
| Hydrothermal method | 2 | Spherical | - | Orthorhombic | [ | |
| Ag2Te | Hydrothermal method | 200 | Wire-type | 995–1300 | Irregular dendrites | [ |
| Solvothermal methods | 10 | Spherical | - | Monoclinic | [ | |
| One-pot aqueous | 3.8–4.7 | - | 995–1068 | Monoclinic | [ | |
| Hydrothermal method | 2.4 ± 0.9 | Spherical | 1320 | Monoclinic | [ | |
| AgInS2 | Hot-injection method | 3.7–4.3 | Spherical | - | - | [ |
| Microwave synthesis | 20–80 | - | 520–650 | Tetragonal | ||
| ZnAgInSe | Synthesized in | 3.5–4 | Spherical | 450–700 | Orthorhombic | [ |
| Hydrothermal synthesis | 1.5–4.5 | Spherical | 450–700 | Cubic | [ |
Figure 3Synthesis of Ag2S QDs using different biological matrices.
«Green» synthesis, photoluminescence, and morphology of Ag-based quantum dots.
| Type of | Living | Average | Morphology | Photoluminescence (nm) | Crystal Lattice Structure | References |
|---|---|---|---|---|---|---|
| Ag2S | 6–12 | Spherical | - | Monoclinic | [ | |
|
| ~20 | Spherical | 387–402 | Monoclinic | [ | |
|
| 360–365 | |||||
|
| 352–354 | |||||
| Chitosan | 343–350 | |||||
|
| 48–54 | Spherical and cubic | 500 | Cubic and individual spherical particles | [ | |
| 10–17 | Spherical | 520 | - | [ | ||
| Sago starch | 9.5 ± 3.6 | Spherical | - | Monoclinic | [ | |
| Ag2Se | Green tea | 30 | Spherical and rod | 240–330 | Orthorhombic | [ |
| Glucose | 31 | Spherical and cubic | ||||
| Ascorbic acid | 96 | Spherical | ||||
| Chitosan | 8 | Spherical | ||||
| Glucose | 2.4 ± 0.5 | - | 561–705 | Orthorhombic | [ | |
| AgInS2 | Shell precursors (ZnAc2 and | 3.2–3.4 | Spherical | 667–677 | Tetragonal | [ |
Optical parameters of organic dyes and QDs.
| Parameter | Dye | QDs |
|---|---|---|
| Absorption | Narrow | Broad and gradually increasing towards shorter wavelength |
| Emission | Broad | Narrow, symmetrical |
| Quantum yield (QY) | High-quality dyes and QDs have similar QYs | |
| Fluorescence | 5–20 nanoseconds | 50–200 nanoseconds |
| Photostability | Poor, rapid photobleaching | Highly stable |
In vitro and in vivo assays for bioimaging of Ag-based QDs.
| Type of QDs | Cell Line/Organism | Fluorescence (nm) | Route of | Reference |
|---|---|---|---|---|
| Ag2S | Mouse fibroblast L929 cell line | 1100–1700 | Cells were fixed in 4% paraformaldehyde and treated with QDs (in vitro studies) | [ |
| Human malignant | ||||
| Human breast cancer MDA-MB-468 cell line (ATCC) | ||||
| Ag2Se | Male CD-1 (ICR) mice | 700–820 | Intravenous injection (in vivo studies) | [ |
| Ag2Te | Male ICR mice | 900–1300 | Intravenous injection (in vivo studies) | [ |
| AgInS2 | Radiation induced fibrosarcoma (RIF) cells | 800 | Intravenous injection (in vivo studies) | [ |
| Human peripheral blood monocyte-derived macrophages (MDM) | ||||
| AgInS2/ZnS | Human hepatoma cell line (Hep G2) | 500–700 | QDs delivered into Hep G2 cells and specifically combined with antigens (in vitro studies) | [ |
Figure 4Confocal microscopy image of Allium cepa epidermal root cells. Exposure time 24 h: (A)—untreated cells; (B)—cells treated with Ag2S QDs; (C)—cells under transmitted light.